Conventional vs. Unconventional Spray Drying Strategies: Development to Commercialization
Recorded on September 30, 2020 | Thermo Fisher Scientific

Leverage spray drying to combat bioavailability and processing challenges. Learn more as global industry experts provide insight from early development to commercialization. Register now.

De-risk Antibody and CAR-T Safety by Identifying Off-target Specificity
Recorded on Tuesday, September 29, 2020 | Integral Molecular Inc

This webinar assembles experts with experience in biotech, pharma, and the FDA to discuss how to best identify the off-target liabilities of antibody and CAR-T therapies that are the primary cause of failure in preclinical and early clinical studies. Register Now

Using Big Data to Take Quality Beyond Compliance
Recorded on: September 24, 2020 | MasterControl

In this webinar, learn how an advanced quality management system (QMS) that connects data across the product life cycle can provide business intelligence insights and give management a better understanding of your processes and how to improve them. Register now.

New vaccines? How to go from zero to serialized in six months.
Recorded on: September 23, 2020 | Systech

Whether you’re developing a COVID-19 treatment or introducing a new drug to the market, serialization is a requirement. Learn why a configurable solution will get you to compliance faster, future-proof your deployments and reduce total cost of ownership. Register now.

Technology Transfers: Best Practices for Optimizing Success and Mitigating Risk
Recorded on September 22, 2020 | Thermo Fisher Scientific

Learn how technology transfers can optimize success and mitigate risk from product development to commercial launch. Register now!

ESMO Postview: Highlights from the virtual conference
Recorded on: September 22, 2020 | Fierce Biotech

Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields. Register now.

Plasmid DNA
FierceMarkets Custom Publishing

This survey will determine different companies' use of Plasmid DNA, if they outsource its manufacture, and how often they use it in their labs. The first 50 qualified respondents will receive a $5 Amazon gift card.  Take Survey.

Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
Recorded on September 17, 2020 | Cambridge Cognition

The widespread adoption of smartphones and wearables makes monitoring symptoms in real time a credible option using brief measures designed for these devices – but is this acceptable and feasible for patients? This webinar will delve into the research findings of Takeda Pharmaceuticals, Cambridge Cognition, and CTRL Group, and share lessons learned adopting new technologies in clinical trials. Register now.

USP Elastomer Chapter Revisions Will Become Official December 2020: What you Need to Know
Recorded on: September 17, 2020 | West Pharmaceutical Services, Inc.

This webinar will explain the baseline requirements for elastomeric physicochemical and functional properties.  Examples to illustrate qualification of components for intended applications will be included.  Register now.

Increasing Patient Adherence for Isolated Populations During the Pandemic: Formulation Strategies Focused on Patient Centric Solutions
Recorded on: September 16, 2020 | Adare Pharmaceuticals

This webinar will focus on the challenges isolated populations have faced during the global pandemic related to patient adherence, and the application of formulation strategies to create more patient centric solutions. Register now.

Accelerating Pharma’s Evolution Towards a Perfect Omnichannel Engagement
Recorded on September 15, 2020 | CSL Behring & Abbott

Do you want to better engage with your customers in the new normal? Do you want to know about the secret sauce to perfecting omni-channel marketing? Join the experts to review the current strategies and discuss the key enablers to driving a personalized customer experience. Register now.

Overcoming Scalability Challenges with Autologous Therapies
Recorded on: September 15, 2020 | Catalent

Join experts Prof. Gerhard Bauer and Catalent’s Dr. James Crutchley as they discuss challenges and an innovative methodology to commercially scale autologous therapies. Register now.

Five Imperatives for Becoming More Patient-Centric
Evidation Health

​​​​​​Becoming patient-centric begins with real-world evidence: Technology drives innovation, but research and trials must be accessible, privacy-safe and return value to participants. Learn how real-world evidence generation is evolving to meet patient needs. Download now.

Leverage Technology to Expedite Master Protocol Trials
4G Clinical

Master protocol studies are meant to increase efficiency and expedite drug development. The challenge is the protocol is amended to follow positive signals, which can be both a costly and slow process. Modern technology is needed to support these complex trial designs to enable flexibility, speed and quality trials. Download now.

Improving Patient Outcomes & Clinical Trials With Visual Analytics
Recorded on September 10, 2020 | Tableau

Drug Development has always been about data.  Research insight that comes from data often gets muddied by its vastness and inaccessibility. In this session we discuss Takeda Pharmaceutical’s Platypus, a comprehensive set of Tableau visualizations of clinical trial data. With the power of Tableau, Takeda is able to more effectively monitor patient safety through all clinical trial phases and help ensure data quality, leading to timely analysis and ultimately a faster path to life-changing medicines that patients need. This session will explore: how to increase quality and speed in data analysis to reduce time and achieve greater results, the impact of Takeda’s approach and user testimonials, and data visualizations, such as “COVID19 Patient Visit Dashboards,” show pandemic insights and enable study teams to view patient data, behavior patterns, and trial delivery milestones. Register Now

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization
Recorded on September 9, 2020 | Thermo Fisher Scientific

This webinar will detail practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, next generation purification resins. It will also showcase best practices and strategies such as phase appropriate quality systems, and integrated drug substance – drug product solutions that leverage standardized technology platforms. Register now!

More Powerful Analytics Capabilities
Acorn AI by Medidata, a Dassault Systèmes company

Acorn AI is a Medidata company that represents the next horizon of the industry leader’s 20-year mission of powering smarter treatments and healthier people. Acorn AI is designed to make data liquid across the entire lifecycle and to answer the most important questions in R&D and commercialization for customers.  Download the case study.

One and Not Quite Done: Gene therapy for Hemophilia
Recorded on: September 3, 2020 | Parexel

The original goal of cell and gene therapy was to deliver a single administration that would maintain therapeutic effectiveness over a patient’s lifetime. This ‘one and done’ model appears to have worked for some gene therapies, where promising follow-up data has been observed. In some instances, however, such as in the case of gene therapy for hemophilia, a single dose may not be enough and redosing may be required. In this webinar, our speakers will discuss: strategies for both one-time and redosing gene therapies, what redosing means for the commercialization strategy, considerations for manufacturing and market access. Register now.

Paid Marketplace
Infographic: Reducing Time to Clinic for Your Biomedical Applications

This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Download now.

Accelerating the Development of Orphan Drugs for Rare Diseases

Worldwide there are over 300 million people living with one or more identified rare diseases. The development of new treatments to address these unmet clinical needs clearly represents an important global health priority. Despite improvements, difficulties remain for drug developers in bringing these medicines to market. Download now >>

Achieving a Successful Drug Product Technology Transfer

Tech transfer is a multifaceted endeavor with multiple variables that must be carefully considered. Get insights on key considerations for a successful process transfer for manufacturing a drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Download now.

Paid Marketplace
Bioscience Certificate Pathways Advancing Knowledge, Skills, & Careers

Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more.

Navigating the Insulin Affordability Act

Extended care programs are available to help people in need. However, as the law rolls out, there are some clear communication disconnections that may make the process cumbersome. Download the eBook to read about a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all.

Reducing barriers to patient care: A cross-industry collaboration
Thursday, August 27, 2020 | 1pm ET / 10am PT | Optum

Optum brings together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address a hard-to-diagnose condition: migraine. Register now.

CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
Recorded on August 26, 2020 | Rho

Hybrid, Virtual, and Synthetic trials are becoming part of a growing number of drug and biologics development programs. Join us as Rho experts discuss how to maximize the benefits of decentralized trials. Register now!

When should your workforce return to the office?
August 26, 2020 | 11 a.m. EST / 8 a.m. PST | Deloitte

Before businesses can recover, they will need to reboot, which will involve developing a holistic approach to managing new health risks, rethinking workforce safety, maximizing productivity, and furthering sales –while protecting and maintaining compliance with privacy and cybersecurity rights. Register now.

QED Therapeutics accelerates launch of rare cancer drug into niche market with analytics-driven insights
Clarify Health

In 2020, QED Therapeutics launched first-in-class infigratinib for cholangiocarcinoma (CCA). Learn how the launch team precisely identified and characterized eligible patients by taking an evidence-based approach to its commercial strategy. Download the case study.

Navigating CMC Regulatory Requirements for Accelerated Commercialization
August 25, 2020 | 11 a.m. EST / 8 a.m. PST | Lonza

Join us to discuss strategy, timing, process, practical and execution aspects to be considered in order to achieve a target  outcome. Case studies will be presented that demonstrate each of these challenges and the considerations necessary to meet fast-track timing requirements of clinical trials and registration applications. Register now.

Powering Virtual Trials – In The Cloud
Recorded on: August 19, 2020 | Amazon Web Services

In this webinar you will hear from technology company uMotif on how they collaborate with pharma companies undertaking virtual and decentralized trials. Hear how new patient populations can be reached using cloud-based technology and learn what types of research data can be collected from different devices and wearables. Register now.

Enabling high drug-loaded amorphous dispersion tablets
Recorded on: August 18, 2020 | Lonza Pharma & Biotech

Join us to gain an understanding of how to combine two different polymers, one “inside” and one “outside” the ASD to maximize performance, physical stability, and drug loading of ASD drug products. Register now.

Uncertainties With the Regulatory Environment for Continuous Manufacturing
August 12, 2020 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing brings uncertainties with regulatory and adoption rates. Industry expert, Ajaz S. Hussain, PhD, will discuss these uncertainties and provide more insight into this innovation. Register now!

Paid Marketplace
Infographic: BOOSTING BIOAVAILABILITY: How Companies are Using Advanced Technologies to Formulate Complex Molecules

To better understand the landscape today, Catalent and FiercePharma asked 200+ people involved in the oral dose market from April to May 2020 for their views on barriers to the development of oral formulations and technological responses to them. Download the infographic now.

Executive Summary
Keys to a Successful Rapid Commercial Launch

Pharmaceutical and biotech companies are spending years and millions of dollars developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Download now.

[eBook] Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Click here to download the eBook.

Paid Marketplace
[Case Study] Using Clinical Supply Management to Overcome Inventory Challenges

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Click here to download the Case Study.

Accelerate Clinical Operations Across Sponsors, CROs, and Partners With a Best-of-Breed Partner Like Box

The complexity of clinical trials is increasing, and patient recruitment and retention continue to pose challenges. New platforms are providing the life sciences industry with an opportunity  to improve the efficiency of clinical trials and reduce costs while remaining compliant and reducing risk. Download the whitepaper to learn more.

Paid Marketplace
[Fact Sheet] Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Download the Fact Sheet here.

High-Loaded Dosage Forms: Novel Platform Expands Spray-Dried Dispersion Utility
Lonza Pharma & Biotech

Spray-dried dispersions (SDDs) are utilized to increase the bioavailability of poorly soluble molecules, however excipient requirements can limit their dose range. A novel platform has been developed to enable SDD dosage forms with high drug loadings, decreasing the size or number of tablets required. Download the whitepaper.

The Art of Recognizing Clinical Supply Risk Factors

In a BioPharma Dive industry survey of 150+ individuals with responsibility for clinical supplies, planning and forecasting were identified as top concerns for trial sponsors and were seen as activities that can yield significant benefits. In response to this need, the Clinical Supply Management (CSM) team at Catalent has developed a factbased methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Download now.

Metabolites in Safety Testing (MIST): Analytical Strategy
July 29, 2020 | 1pm EST / 10am PST | Frontage Laboratories

Regulatory agencies have provided recommendations on when and how to identify and characterize drug metabolites to ensure their non-clinical toxicity has been adequately evaluated. The studies conducted to comply with these recommendations are often referred to as metabolites in safety testing or MIST.

This presentation will review the origins of these recommendations and the specific requirements that need to be considered in designing studies to address the regulatory expectations. Register now.

Patients can’t wait: Advancing Rare Disease & Oncology drug development during COVID-19
Recorded on: July 28, 2020 | Parexel

This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation. Register now to learn more.

Bioavailability Toolkit
FierceMarkets Custom Publishing

This industry survey seeks to gain insight on the drug developer’s perspective on bioavailability enhancement technologies and the reasoning behind the use of certain technologies over others in preclinical and early-stage clinical development. Take the survey for a chance to win a $5 Amazon gift card.

Challenges and Practical Solutions for Changing Over to Pre-filled Syringes for Parenteral Drugs
Recorded on July 22, 2020 | Thermo Fisher Scientific

It’s not uncommon for companies who launch commercial drug products in the pre-filled syringe format to do so after initially using other product formats such as vials for the development and clinical trial phases. Switch-overs need careful and strategic consideration because doing so requires investment in the new format but also offers critical patient benefits and improved stakeholder outcomes. During this webinar, you will learn more about benefits and risks of changing primary components during product development and how a design of experiments approach can be used to address issues and risks. Register now.

Zero Deviation Mindset: Achieving Agility in Cell Therapy Supply Chains
Recorded on July 21, 2020 | Pluristem Therapeutics & ThermoFisher Scientific

Cell & gene therapy supply chains are inherently complex, requiring the utmost attention to quality, cold chain logistics, and chain of custody requirements. Join Thermo Fisher Scientific and Pluristem Therapeutics as we discuss lessons learned in developing the just-in-time supply chain for their phase III hip fracture study, and how these lessons are being used in their current efforts to treat severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome (ARDS) in the United States. Register Now.

BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury
July 16, 2020 | 1pm EST / 10am PST | Frontage Laboratories

This presentation will benefit scientists wanting to learn more about DILI and/or those needing guidance on crucial transporter studies for better assessment of DDI potentials that is aligned with regulatory guidance. Register for our Webinar, featuring Kan He, on BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury.

EMD Serono & Aktana: Bringing Intelligent Engagement to Every Channel
Recorded on: Tuesday, July 14, 2020 | Aktana

Join this webinar to hear Joel VanderMeulen, Senior Director, N&I Commercial Strategy and Operations at EMD Serono, and Derek Choy, Co-founder and President at Aktana, discuss:

  • Emerging market trends in the post-COVID world
  • How commercial teams can adapt to the “next normal” 
  • The three key components for successful omnichannel engagement

Register now.

Becoming the early bird: Establishing a dialogue with the FDA around accelerating preclinical research
Recorded on: July 14, 2020 | Box

By establishing an early dialogue with the FDA—when potential products are still in preclinical testing—companies can gain valuable insights that could boost their chances of success. This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Register now.

De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools
Recorded on: July 8, 2020 | Lonza

There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost.  Register for the webinar to learn more.

Paid Marketplace
Webinar, July 8: Oncology in the Era of Precision Medicine
Sponsored by University of Florida College of Pharmacy

University of Florida precision medicine leaders highlight current knowledge and trends to advance the future of health care in this quarterly webinar series. Register today.

Paid Marketplace
Case Study: The Script Lift Impact of Weekly Alert Data On Non Personal Promotion
TI Health

With pharma sales reps sidelined by COVID, communication with professionals is more important now than ever before. TI Health is responding to weekly EMR and Telehealth fueled data feeds, to engage and target 600,000+ professionals who are newly diagnosing and treating patients in your disease states. Download the case study now.